Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) saw unusually-strong trading volume on Thursday . Approximately 1,995,441 shares were traded during trading, an increase of 93% from the previous session’s volume of 1,034,818 shares.The stock last traded at $36.27 and had previously closed at $38.11.

Several analysts have recently commented on ZLTQ shares. Leerink Swann restated a “buy” rating on shares of Zeltiq Aesthetics in a research report on Thursday, June 30th. Brean Capital restated a “buy” rating and set a $35.00 price objective on shares of Zeltiq Aesthetics in a research report on Tuesday, June 21st. TheStreet upgraded shares of Zeltiq Aesthetics from a “hold” rating to a “buy” rating in a research report on Wednesday, April 20th. Stifel Nicolaus restated a “buy” rating and set a $38.00 price objective on shares of Zeltiq Aesthetics in a research report on Friday, May 13th. Finally, Maxim Group raised their price objective on shares of Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday. Three analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $38.33.

The company has a market cap of $1.50 billion and a P/E ratio of 56.90. The stock’s 50 day moving average price is $31.49 and its 200 day moving average price is $27.26.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last released its quarterly earnings data on Monday, August 8th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.07. The firm had revenue of $89.50 million for the quarter, compared to analyst estimates of $79.68 million. During the same quarter in the prior year, the business earned $0.03 earnings per share. Zeltiq Aesthetics’s revenue was up 38.9% on a year-over-year basis. Analysts predict that Zeltiq Aesthetics Inc. will post ($0.07) earnings per share for the current year.

In other news, Director Andrew N. Schiff sold 500,000 shares of the company’s stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $36.39, for a total value of $18,195,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Bradley Hauser sold 3,000 shares of the company’s stock in a transaction on Monday, July 11th. The shares were sold at an average price of $30.02, for a total transaction of $90,060.00. Following the completion of the sale, the vice president now directly owns 47,184 shares in the company, valued at $1,416,463.68. The disclosure for this sale can be found here.

Several hedge funds have added to or reduced their stakes in the stock. Wells Fargo & Company MN increased its stake in Zeltiq Aesthetics by 765.2% in the fourth quarter. Wells Fargo & Company MN now owns 404,376 shares of the company’s stock valued at $11,537,000 after buying an additional 357,636 shares during the period. State of Tennessee Treasury Department acquired a new stake in Zeltiq Aesthetics during the fourth quarter valued at approximately $2,853,000. Trexquant Investment LP acquired a new stake in Zeltiq Aesthetics during the fourth quarter valued at approximately $1,640,000. New York State Common Retirement Fund increased its stake in Zeltiq Aesthetics by 4.3% in the fourth quarter. New York State Common Retirement Fund now owns 41,532 shares of the company’s stock valued at $1,185,000 after buying an additional 1,700 shares during the period. Finally, California State Teachers Retirement System increased its stake in Zeltiq Aesthetics by 1.7% in the fourth quarter. California State Teachers Retirement System now owns 59,726 shares of the company’s stock valued at $1,704,000 after buying an additional 984 shares during the period.

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.